Analyzes myelin content in lesions and normal-appearing tissue in MOGAD compared to MS and healthy controls, suggesting differences in myelin integrity.
To analyze myelin content within lesions and in the normal-appearing (NA) brain tissue in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) versus multiple sclerosis (MS) and healthy controls (HC).
No takes yet. Share an insight, caveat, or question.
Cacciaguerra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: